Monique Tavares

2PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jun 05, 2024
Real-World Study of Adjuvant Biosimilar Trastuzumab-dkst for HER2-Positive Breast Cancer Treatment in a Brazilian Population.

Debora Gagliato, Tomás Reinert, Cláudio Rocha

|Aug 19, 2021
HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.

Luciana de Moura Leite, Marcelle Goldner Cesca, Monique Celeste Tavares

Pageof 1

Frequent Collaborators

1 joint publications

Luciana de Moura Leite

1 joint publications

Marcelle Goldner Cesca

1 joint publications

Erick Figueiredo Saldanha

1 joint publications

Daniella Dias Silva Sá

1 joint publications

Maria Fernanda Evangelista Simões

1 joint publications

Rafael Lima Viana

1 joint publications

Rafaela Pirolli

1 joint publications

Camilla Albina Zanco Fogassa

1 joint publications

Fernando Augusto Batista Campos

1 joint publications

Solange Moraes Sanches

Frequent Collaborators

1 joint publications

Luciana de Moura Leite

1 joint publications

Marcelle Goldner Cesca

1 joint publications

Erick Figueiredo Saldanha

1 joint publications

Daniella Dias Silva Sá

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

2.6K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.8K
See more related videos

Top Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on : Apr 26, 2024

2.6K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on : Dec 05, 2017

12.8K
See more related videos